← Back to patent-cliff list
CAS 796848-79-8
1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea
Codes：LENT-015
Application context (from source-drug indications)
肾细胞癌甲磺酸仑伐替尼子宫内膜癌甲磺酸仑伐替尼肝细胞癌甲磺酸仑伐替尼甲状腺瘤甲磺酸仑伐替尼
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 甲磺酸仑伐替尼Lenvatinib Mesilate | Tier A — Act now | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-chloro-7-methoxyquinoline-6-carboxamide→4-amino-3-chlorophenol→phenyl carbonochloridate→cyclopropanamine→phenyl (2-chloro-4-hydroxyphenyl)carbamate→1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.